Comparative Pharmacology
Head-to-head clinical analysis: MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER versus POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5 AND SODIUM CHLORIDE 0 3 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER versus POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5 AND SODIUM CHLORIDE 0 3 IN PLASTIC CONTAINER.
MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER vs POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Magnesium sulfate provides magnesium ions, which are essential for various physiological processes. It acts as a cofactor for enzymatic reactions, stabilizes excitable membranes, and antagonizes calcium entry at the neuromuscular junction, leading to reduced acetylcholine release and muscle relaxation. In the CNS, it may act as a noncompetitive antagonist of NMDA receptors, exerting anticonvulsant effects.
Potassium chloride provides potassium ions for cellular ion exchange, restoring normal electrolyte balance, membrane potential, and acid-base regulation. Dextrose 5% is a caloric source, and sodium chloride 0.3% supplies sodium and chloride to maintain extracellular fluid tonicity.
1 to 4 g intravenously as a 5% to 20% solution, rate not exceeding 150 mg/min; dosing frequency depends on indication (e.g., preeclampsia/eclampsia: 4-5 g IV loading then 1-2 g/hr infusion; hypomagnesemia: 1-2 g IV over 1-2 hours, may repeat based on serum magnesium levels).
Intravenous infusion. Typical adult dose is 40 mEq potassium chloride in 1000 mL of D5NS (D5 0.3% NaCl) infused at a rate not exceeding 10 mEq/hour (or 250 mL/hour of this solution). Maximum 24-hour dose usually 200 mEq.
None Documented
None Documented
Terminal half-life approximately 4-5 hours in normal renal function; prolonged in renal impairment (up to 40 hours).
Terminal half-life of potassium is approximately 6-8 hours in patients with normal renal function; may be prolonged in renal impairment.
Primarily renal (90-100% as unchanged magnesium). Less than 1% biliary/fecal.
Renal excretion of potassium >90% as K+ ions; glucose metabolism yields CO2 and water; sodium and chloride are excreted renally. Minimal biliary/fecal elimination.
Category C
Category A/B
Electrolyte
Electrolyte